Derlin T

ORCID: 0000-0002-8786-4105 · 1 paper in corpus

2020

Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] ·doi:10.1007/s00066-020-01629-5

PurposeTo assess the outcome of prostate cancer (PCa) patients diagnosed with oligorecurrent disease and treated with a first and a second PSMA (prostate-specific membrane antigen ligand) PET(positron-emission tomography)-directed radiother…